Zebrafish models for cancer

Annual Review of Pathology: Mechanisms of Disease

Volumn 6, Issue , 2011, Pages 71-93

  Liu, Shu ^a   Leach, Steven D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

forward genetics; TILLING; transgenesis; transplantation; ZFN

Indexed keywords

K RAS PROTEIN; NUCLEASE; PROTEIN P53; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE; ZINC FINGER PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER MODEL; CANCER RESEARCH; CARCINOGENESIS; GENE INACTIVATION; GENE SILENCING; GENETIC SCREENING; GENETICS; HISTOLOGY; HUMAN; IN VIVO STUDY; MELANOMA; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RNA INTERFERENCE; TRANSGENICS; TRANSPLANTATION; TUMOR GENE; ZEBRA FISH;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; NEOPLASMS; ZEBRAFISH;

EID: 79751468871     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-011110-130330     Document Type: Article

References (145)

1. Stanton MF. 1965. Diethylnitrosamine-induced hepatic degeneration and neoplasia in the aquarium fish, Brachydanio rerio. J. Natl. Cancer Inst. 34:117-30
2. Streisinger G, Walker C, Dower N, Knauber D, Singer F. 1981. Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature 291:293-96 (Pubitemid 11083423)
3. Grunwald DJ, Eisen JS. 2002. Timeline-headwaters of the zebrafish emergence of a new model vertebrate. Nat. Rev. Genet. 3:717-24 (Pubitemid 34984260)
4. Driever W, Solnica-Krezel L, Schier AF, Neuhauss SC, Malicki J, et al. 1996. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123:37-46 (Pubitemid 27056734)
5. Mullins MC, Hammerschmidt M, Kane DA, Odenthal J, Brand M, et al. 1996. Genes establishing dorsoventral pattern formation in the zebrafish embryo: the ventral specifying genes. Development 123:81-93 (Pubitemid 27056738)
6. Amatruda JF, Shepard JL, Stern HM, Zon LI. 2002. Zebrafish as a cancer model system. Cancer Cell 1:229-31 (Pubitemid 41039146)
7. Solnica-Krezel L, Schier AF, Driever W. 1994. Efficient recovery of ENU-induced mutations from the zebrafish germline. Genetics 136:1401-20 (Pubitemid 24097868)
8. Stuart GW, McMurray JV, Westerfield M. 1988. Replication, integration and stable germ-line transmission of foreign sequences injected into early zebrafish embryos. Development 103:403-12
9. Stuart GW, Vielkind JR, McMurray JV, Westerfield M. 1990. Stable lines of transgenic zebrafish exhibit reproducible patterns of transgene expression. Development 109:577-84 (Pubitemid 20228652)
10. Culp P, Nusslein-Volhard C, Hopkins N. 1991. High-frequency germ-line transmission of plasmid DNA sequences injected into fertilized zebrafish eggs. Proc. Natl. Acad. Sci. USA 88:7953-57 (Pubitemid 21915273)
11. Gibbs PD, Peek A, Thorgaard G. 1994. An in vivo screen for the luciferase transgene in zebrafish. Mol. Mar. Biol. Biotechnol. 3:307-16
12. Thummel R, Burket CT, Hyde DR. 2006. Two different transgenes to study gene silencing and reexpression during zebrafish caudal fin and retinal regeneration. Sci. World J. 6(Suppl. 1):65-81 (Pubitemid 46155750)
13. Thermes V, Grabher C, Ristoratore F, Bourrat F, Choulika A, et al. 2002. I-SceI meganuclease mediates highly efficient transgenesis in fish. Mech. Dev. 118:91-98 (Pubitemid 35292124)
14. Gaiano N, Allende M, Amsterdam A, Kawakami K, Hopkins N. 1996. Highly efficient germ-line transmission of proviral insertions in zebrafish. Proc. Natl. Acad. Sci. USA 93:7777-82 (Pubitemid 26277114)
15. Kawakami K, Koga A, Hori H, Shima A. 1998. Excision of the tol2 transposable element of the medaka fish, Oryzias latipes, in zebrafish, Danio rerio. Gene 225:17-22 (Pubitemid 29030430)
16. Kawakami K, Shima A. 1999. Identification of the Tol2 transposase of the medaka fish Oryzias latipes that catalyzes excision of a nonautonomous Tol2 element in zebrafish Danio rerio. Gene 240:239-44 (Pubitemid 29519981)
17. Kawakami K, Shima A, Kawakami N. 2000. Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage. Proc. Natl. Acad. Sci. USA 97:11403-8
18. ChenW,Burgess S,GollingG, AmsterdamA,HopkinsN. 2002. High-throughput selection of retrovirus producer cell lines leads to markedly improved efficiency of germ line-transmissible insertions in zebra fish. J. Virol. 76:2192-98 (Pubitemid 34150686)
19. Raz E, van Luenen HG, Schaerringer B, Plasterk RH, Driever W. 1998. Transposition of the nematode Caenorhabditis elegans Tc3 element in the zebrafish Danio rerio. Curr. Biol. 8:82-88 (Pubitemid 28104520)
20. Davidson AE, Balciunas D, Mohn D, Shaffer J, Hermanson S, et al. 2003. Efficient gene delivery and gene expression in zebrafish using the Sleeping Beauty transposon. Dev. Biol. 263:191-202 (Pubitemid 37338603)
21. Fadool JM, Hartl DL, Dowling JE. 1998. Transposition of the mariner element from Drosophila mauritiana in zebrafish. Proc. Natl. Acad. Sci. USA 95:5182-86 (Pubitemid 28208572)
22. Linney E, Hardison NL, Lonze BE, Lyons S, DiNapoli L. 1999. Transgene expression in zebrafish: a comparison of retroviral-vector and DNA-injection approaches. Dev. Biol. 213:207-16 (Pubitemid 29409958)
23. Kawakami K. 2004. Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element. Methods Cell Biol. 77:201-22
24. Kawakami K. 2007. Tol2: a versatile gene transfer vector in vertebrates. Genome Biol. 8(Suppl. 1):S7
25. Halpern ME, Rhee J, Goll MG, Akitake CM, Parsons M, Leach SD. 2008. Gal4/UAS transgenic tools and their application to zebrafish. Zebrafish 5:97-110 (Pubitemid 351860474)
26. Guarente L, Yocum RR, Gifford P. 1982. A GAL10-CYC1 hybrid yeast promoter identifies the GAL4 regulatory region as an upstream site. Proc. Natl. Acad. Sci. USA 79:7410-14 (Pubitemid 13179117)
27. Carey M, Kakidani H, Leatherwood J, Mostashari F, Ptashne M. 1989. An amino-terminal fragment of GAL4 binds DNA as a dimer. J. Mol. Biol. 209:423-32 (Pubitemid 19260007)
28. Giniger E, Varnum SM, Ptashne M. 1985. SpecificDNA binding of GAL4, a positive regulatory protein of yeast. Cell 40:767-74 (Pubitemid 15240282)
29. Giniger E, Ptashne M. 1987. Transcription in yeast activated by a putative amphipathic áhelix linked to a DNA binding unit. Nature 330:670-72 (Pubitemid 18005586)
30. Sadowski I, Ma J, Triezenberg S, Ptashne M. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563-64
31. Inbal A, Topczewski J, Solnica-Krezel L. 2006. Targeted gene expression in the zebrafish prechordal plate. Genesis 44:584-88 (Pubitemid 46047868)
32. Scheer N, Groth A, Hans S, Campos-Ortega JA. 2001. An instructive function for Notch in promoting gliogenesis in the zebrafish retina. Development 128:1099-107 (Pubitemid 32401425)
33. Scheer N, Campos-Ortega JA. 1999. Use of the Gal4-UAS technique for targeted gene expression in the zebrafish. Mech. Dev. 80:153-58 (Pubitemid 29125426)
34. Hans S, Scheer N, Riedl I, von Weizsäcker E, Blader P, Campos-Ortega JA. 2004. her3, a zebrafish member of the hairy-E(spl ) family, is repressed by Notch signaling. Development 131:2957-69 (Pubitemid 38997283)
35. Koster RW, Fraser SE. 2001. Tracing transgene expression in living zebrafish embryos. Dev. Biol. 233:329-46 (Pubitemid 32467680)
36. Campbell DS, Stringham SA, Timm A, Xiao T, LawMY, et al. 2007. Slit1a inhibits retinal ganglion cell arborization and synaptogenesis via Robo2-dependent and-independent pathways. Neuron 55:231-45 (Pubitemid 47053990)
37. Sato T, Hamaoka T, Aizawa H, Hosoya T, Okamoto H. 2007. Genetic single-cell mosaic analysis implicates ephrinB2 reverse signaling in projections from the posterior tectum to the hindbrain in zebrafish. J. Neurosci. 27:5271-79 (Pubitemid 46790155)
38. Zecchin E, Filippi A, Biemar F, Tiso N, Pauls S, et al. 2007. Distinct äand jagged genes control sequential segregation of pancreatic cell types from precursor pools in zebrafish. Dev. Biol. 301:192-204 (Pubitemid 44958397)
39. Anelli V, Santoriello C, Distel M, Koster RW, Ciccarelli FD, Mione M. 2009. Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation. Zebrafish 6:417-24
40. BirlingMC, Gofflot F, WarotX. 2009. Site-specific recombinases for manipulation of the mouse genome. Methods Mol. Biol. 561:245-63
41. .41. LangenauDM,FengH, Berghmans S, Kanki JP, Kutok JL, Look AT. 2005. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 102:6068-73 (Pubitemid 40594256)
42. Le X, Langenau DM, KeefeMD, Kutok JL, Neuberg DS, Zon LI. 2007. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc. Natl. Acad. Sci. USA 104:9410-15 (Pubitemid 47185793)
43. Langenau DM, Keefe MD, Storer NY, Guyon JR, Kutok JL, et al. 2007. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 21:1382-95 (Pubitemid 46871041)
44. Feng H, Langenau DM,Madge JA, Quinkertz A,Gutierrez A, et al. 2007. Heat-shock induction of T-cell lymphoma/leukaemia in conditionalCre/lox- regulated transgenic zebrafish.Br. J. Haematol. 138:169-75 (Pubitemid 46976317)
45. Pan X, Wan H, Chia W, Tong Y, Gong Z. 2005. Demonstration of site-directed recombination in transgenic zebrafish using the Cre/loxP system. Transgenic Res. 14:217-23 (Pubitemid 40747900)
46. Thummel R, Burket CT, Brewer JL, Sarras MP Jr, Li L, et al. 2005. Cre-mediated site-specific recombination in zebrafish embryos. Dev. Dyn. 233:1366-77 (Pubitemid 40995134)
47. Boniface EJ, Lu J, Victoroff T, Zhu M, Chen W. 2009. FlEx-based transgenic reporter lines for visualization of Cre and Flp activity in live zebrafish. Genesis 47:484-91
48. Hardy ME, Ross LV, Chien CB. 2007. Focal gene misexpression in zebrafish embryos induced by local heat shock using a modified soldering iron. Dev. Dyn. 236:3071-76 (Pubitemid 350175004)
49. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, et al. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifeninducible Cre-ERT and Cre-ERT2 recombinases. Nucleic Acids Res. 27:4324-27 (Pubitemid 29533170)
50. Emelyanov A, Parinov S. 2008. Mifepristone-inducible LexPR system to drive and control gene expression in transgenic zebrafish. Dev. Biol. 320:113-21
51. Hans S, Kaslin J, Freudenreich D, Brand M. 2009. Temporally-controlled site-specific recombination in zebrafish. PLoS One 4:e4640
52. Huang CJ, Jou TS, Ho YL, Lee WH, Jeng YT, et al. 2005. Conditional expression of a myocardiumspecific transgene in zebrafish transgenic lines. Dev. Dyn. 233:1294-303
53. Wienholds E, Schulte-Merker S, Walderich B, Plasterk RH. 2002. Target-selected inactivation of the zebrafish rag1 gene. Science 297:99-102 (Pubitemid 34743101)
54. Wienholds E, van Eeden F, Kosters M, Mudde J, Plasterk RH, Cuppen E. 2003. Efficient target-selected mutagenesis in zebrafish. Genome Res. 13:2700-7 (Pubitemid 37541159)
55. Hurlstone AF, Haramis AP, Wienholds E, Begthel H, Korving J, et al. 2003. The Wnt/â-catenin pathway regulates cardiac valve formation. Nature 425:633-37 (Pubitemid 37280148)
56. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, et al. 2005. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. USA 102:407-12 (Pubitemid 40116780)
57. Faucherre A, Taylor GS,Overvoorde J, Dixon JE, Hertog J. 2008. Zebrafish pten genes have overlapping and nonredundant functions in tumorigenesis and embryonic development. Oncogene 27:1079-86 (Pubitemid 351255509)
58. Meng X, Noyes MB, Zhu LJ, Lawson ND, Wolfe SA. 2008. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat. Biotechnol. 26:695-701 (Pubitemid 351809594)
59. Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, et al. 2008. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat. Biotechnol. 26:702-8 (Pubitemid 351809597)
60. Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, et al. 2008. Rapid "opensource" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell 31:294-301 (Pubitemid 352001401)
61. Foley JE, Yeh JR, Maeder ML, Reyon D, Sander JD, et al. 2009. Rapidmutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS One 4:e4348
62. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-54 (Pubitemid 24014542)
63. Wightman B, Ha I, Ruvkun G. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75:855-62 (Pubitemid 24014543)
64. Plasterk RH. 2002. RNA silencing: the genome's immune system. Science 296:1263-65 (Pubitemid 34522772)
65. Zamore PD. 2002. Ancient pathways programmed by small RNAs. Science 296:1265-69 (Pubitemid 34522773)
66. Martin SE, Caplen NJ. 2007. Applications of RNA interference in mammalian systems. Annu. Rev. Genomics Hum. Genet. 8:81-108
67. Skromne I, Prince VE. 2008. Current perspectives in zebrafish reverse genetics: moving forward. Dev. Dyn. 237:861-82 (Pubitemid 351542286)
68. Ekker SC. 2000. Morphants: a new systematic vertebrate functional genomics approach. Yeast 17:302-6 (Pubitemid 32051423)
69. Nasevicius A, Ekker SC. 2000. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26:216-20
70. Dong M, Fu YF, Du TT, Jing CB, Fu CT, et al. 2009. Heritable and lineage-specific gene knockdown in zebrafish embryo. PLoS One 4:e6125
71. Zilfou JT, Lowe SW. 2009. Tumor suppressive functions of p53. Cold Spring Harb. Perspect. Biol. 1:a001883
72. Beroud C, Soussi T. 2003. The UMD-p53 database: new mutations and analysis tools. Hum. Mutat. 21:176-81 (Pubitemid 36292960)
73. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat. 19:607-14 (Pubitemid 34556481)
74. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-38 (Pubitemid 120031831)
75. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-21
76. Attardi LD, Jacks T. 1999. The role of p53 in tumor suppression: lessons from mouse models. Cell Mol. Life Sci. 55:48-63 (Pubitemid 29077854)
77. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, et al. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1-7
78. Lee KC, Goh WL, Xu M, Kua N, Lunny D, et al. 2008. Detection of the p53 response in zebrafish embryos using new monoclonal antibodies. Oncogene 27:629-40 (Pubitemid 351158905)
79. Langheinrich U, Hennen E, Stott G, VacunG. 2002. Zebrafish as amodel organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr. Biol. 12:2023-28 (Pubitemid 35450925)
80. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, et al. 2004. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119:861-72 (Pubitemid 40017691)
81. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, et al. 2004. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119:847-60 (Pubitemid 40017690)
82. Ghosh P, Chin L. 2009. Genetics and genomics of melanoma. Expert Rev. Dermatol. 4:131-43
83. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-54 (Pubitemid 34716871)
84. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, et al. 2005. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 15:249-54 (Pubitemid 40205706)
85. Dovey M, White RM, Zon LI. 2009. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish 6:397-404
86. Onciu M. 2009. Acute lymphoblastic leukemia. Hematol. Oncol. Clin. N. Am. 23:655-74
87. SabaawyHE, AzumaM, Embree LJ, Tsai HJ, Starost MF,Hickstein DD. 2006. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 103:15166-71 (Pubitemid 44583182)
88. Andreasson P, Schwaller J,Anastasiadou E, Aster J, GillilandDG.2001. The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet. Cytogenet. 130:93-104 (Pubitemid 33033225)
89. Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, et al. 2003. Myc-induced T cell leukemia in transgenic zebrafish. Science 299:887-90 (Pubitemid 36182446)
90. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, et al. 2002. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75-87 (Pubitemid 41039178)
91. Adams JM, Harris AW, Strasser A, Ogilvy S, Cory S. 1999. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene 18:5268-77 (Pubitemid 29462362)
92. WengAP, Ferrando AA, LeeW,Morris JP, SilvermanLB, et al. 2004. Activating mutations ofNOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-71 (Pubitemid 39336870)
93. Lee SY, Kumano K, Masuda S, Hangaishi A, Takita J, et al. 2005. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia 19:1841-43 (Pubitemid 41486167)
94. MansourMR,LinchDC,ForoniL,Goldstone AH,Gale RE. 2006. High incidence of Notch-1mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia 20:537-39 (Pubitemid 43291764)
95. ZhuYM, ZhaoWL,Fu JF, Shi JY, PanQ, et al. 2006.NOTCH1mutations inT-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin. Cancer Res. 12:3043-49 (Pubitemid 43837349)
96. Girard L, Hanna Z, Beaulieu N, Hoemann CD, Simard C, et al. 1996. Frequent provirus insertional mutagenesis ofNotch1 in thymomas of MMTVD/myc transgenicmice suggests a collaboration of c-myc and Notch1 for oncogenesis. Genes Dev. 10:1930-44 (Pubitemid 26281687)
97. Feldman BJ, Hampton T, Cleary ML. 2000. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice. Blood 96:1906-13 (Pubitemid 30661076)
98. Beverly LJ, Capobianco AJ. 2003. Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in NotchIC-induced T cell leukemogenesis. Cancer Cell 3:551-64 (Pubitemid 36808650)
99. Chen J, Jette C, Kanki JP, Aster JC, Look AT, Griffin JD. 2007. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 21:462-71
100. Langenau DM, Jette C, Berghmans S, Palomero T, Kanki JP, et al. 2005. Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood 105:3278-85
101. Kalev-ZylinskaML, Horsfield JA, Flores MV, Postlethwait JH, Vitas MR, et al. 2002. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 129:2015-30 (Pubitemid 34874216)
102. Onnebo SM, Condron MM, McPhee DO, Lieschke GJ, Ward AC. 2005. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp. Hematol. 33:182-88 (Pubitemid 40164900)
103. Yeh JR, Munson KM,Chao YL, Peterson QP,Macrae CA, Peterson RT. 2008. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development 135:401-10 (Pubitemid 351228431)
104. Lowenfels AB, Maisonneuve P. 2006. Epidemiology and risk factors for pancreatic cancer. Best Pract. Res. Clin. Gastroenterol. 20:197-209
105. Maitra A, Hruban RH. 2008. Pancreatic cancer. Annu. Rev. Pathol. Mech. Dis. 3:157-88 (Pubitemid 351488279)
106. Caldas C, Kern SE. 1995. K-ras mutation and pancreatic adenocarcinoma. Int. J. Pancreatol. 18:1-6
107. Hingorani SR, Petricoin EF,Maitra A, Rajapakse V, King C, et al. 2003. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4:437-50 (Pubitemid 38050041)
108. Jonsson J, Carlsson L, Edlund T, Edlund H. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606-9 (Pubitemid 24315741)
109. Krapp A, Knofler M, Ledermann B, Burki K, Berney C, et al. 1998. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 12:3752-63 (Pubitemid 29019655)
110. Fleming JB, Shen GL, Holloway SE, DavisM, Brekken RA. 2005. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy. Mol. Cancer Res. 3:413-23 (Pubitemid 41045591)
111. Xing HR, Cordon-Cardo C, Deng X, Tong W, Campodonico L, et al. 2003. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat. Med. 9:1266-68 (Pubitemid 37279848)
112. Brembeck FH, Schreiber FS, Deramaudt TB, Craig L, Rhoades B, et al. 2003. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 63:2005-9 (Pubitemid 36538597)
113. Habbe N, Shi G, MeguidRA, Fendrich V, Esni F, et al. 2008. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc. Natl. Acad. Sci. USA 105:18913-18
114. De La OJ, Emerson LL, Goodman JL, Froebe SC, Illum BE, et al. 2008. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl. Acad. Sci. USA 105:18907-12
115. Guerra C, Schuhmacher AJ, Canamero M, Grippo PJ, Verdaguer L, et al. 2007. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-ras oncogenes in adult mice. Cancer Cell 11:291-302 (Pubitemid 46349841)
116. Park SW, Davison JM, Rhee J, Hruban RH, Maitra A, Leach SD. 2008. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 134:2080-90 (Pubitemid 351783259)
117. Tuveson DA, ZhuL,Gopinathan A, Willis NA,Kachatrian L, et al. 2006. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res. 66:242-47 (Pubitemid 43166030)
118. Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, et al. 2003. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17:3112-26 (Pubitemid 38040774)
119. Bardeesy N, Aguirre AJ, Chu GC, Cheng KH, Lopez LV, et al. 2006. Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. USA 103:5947-52
120. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, et al. 2005. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7:469-83 (Pubitemid 40719130)
121. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-6
122. Tidyman WE, Rauen KA. 2009. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr. Opin. Genet. Dev. 19:230-36
123. Groden J,Thliveris A, SamowitzW,CarlsonM,Gelbert L, et al. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
124. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, et al. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661-65 (Pubitemid 21917199)
125. Ward JM, Devor-Henneman DE. 2004. Mouse models of human familial cancer syndromes. Toxicol. Pathol. 32(Suppl. 1):90-98 (Pubitemid 38437572)
126. Haramis AP, Hurlstone A, van der Velden Y, Begthel H, van den Born M, et al. 2006. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep. 7:444-49
127. Croushore JA, Blasiole B, Riddle RC, Thisse C, Thisse B, et al. 2005. ptena and ptenb genes play distinct roles in zebrafish embryogenesis. Dev. Dyn. 234:911-21 (Pubitemid 41741163)
128. YangHW,Kutok JL,Lee NH, Piao HY, FletcherCD, et al. 2004. Targeted expression of humanMYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res. 64:7256-62 (Pubitemid 39372062)
129. Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT, et al. 2004. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2:E139
130. Sadler KC, Amsterdam A, Soroka C, Boyer J, Hopkins N. 2005. A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development 132:3561-72 (Pubitemid 41246129)
131. Lai K, Amsterdam A, Farrington S, Bronson RT, Hopkins N, Lees JA. 2009. Many ribosomal protein mutations are associated with growth impairment and tumor predisposition in zebrafish. Dev. Dyn. 238:76-85
132. MacInnes AW, Amsterdam A, Whittaker CA, Hopkins N, Lees JA. 2008. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc. Natl. Acad. Sci. USA 105:10408-13
133. Shepard JL, Amatruda JF, Stern HM, Subramanian A, FinkelsteinD, et al. 2005. A zebrafish bmybmutation causes genome instability and increased cancer susceptibility. Proc.Natl. Acad. Sci.USA102:13194-99 (Pubitemid 41325000)
134. Shepard JL, Amatruda JF, Finkelstein D, Ziai J, Finley KR, et al. 2007. A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev. 21:55-59 (Pubitemid 46089707)
135. Neumann JC, Dovey JS, Chandler GL, Carbajal L, Amatruda JF. 2009. Identification of a heritable model of testicular germ cell tumor in the zebrafish. Zebrafish 6:319-27
136. Moore JL, Rush LM, Breneman C, Mohideen MA, Cheng KC. 2006. Zebrafish genomic instability mutants and cancer susceptibility. Genetics 174:585-600 (Pubitemid 44656452)
137. StreisingerG,Coale F, Taggart C, Walker C, Grunwald DJ. 1989. Clonal origins of cells in the pigmented retina of the zebrafish eye. Dev. Biol. 131:60-69 (Pubitemid 19032125)
138. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, et al. 2008. Transparent adult zebrafish as a tool for in transplantation analysis. Cell Stem Cell 2:183-89 (Pubitemid 351168711)
139. Taylor AM, Zon LI. 2009. Zebrafish tumor assays: the state of transplantation. Zebrafish 6:339-46
140. Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ. 2005. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev. Dyn. 233:1560-70 (Pubitemid 40995154)
141. Topczewska JM, Postovit LM, MargaryanNV, Sam A,Hess AR, et al. 2006. Embryonic and tumorigenic pathways converge via nodal signaling: role in melanoma aggressiveness. Nat. Med. 12:925-32 (Pubitemid 44175144)
142. Haldi M, Ton C, Seng WL, McGrath P. 2006. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 9:139-51 (Pubitemid 46232205)
143. Nicoli S, Ribatti D, Cotelli F, Presta M. 2007. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res. 67:2927-31
144. Stoletov K, Montel V, Lester RD,Gonias SL, Klemke R. 2007. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl. Acad. Sci. USA 104:17406-11 (Pubitemid 350219851)
145. Snaar-Jagalska BE. 2009. ZF-CANCER: developing high-throughput bioassays for human cancers in zebrafish. Zebrafish 6:441-43